| About Us |
| News & Events |
| Research |
| Publications |
| Affiliates |
| Cores |
 Biomolecule Production |
| High-throughput Screening |
| Live-cell Imaging |
| Microbiology and Animal Resources |
| Other Resources |
| Confocal Microscope |
| FACS |
| Mass Spectrometry |
| NMR |
| RNAi |
| NIAID/NIH Research |
| Useful Links |
| Contact Information |
| News & Events Archives |
| Copyright © 2009 by the President and Fellows of Harvard College |
Alileche A, Squires RC, Muehlbauer SM, Lisanti MP, and Brojatsch J (2006). Mitochondrial impairment is a critical event in anthrax lethal toxin-induced cytolysis of murine macrophages. Cell Cycle 5, 100-106.
Cai S, Kukreja R, Shoesmith S, Chang TW, and Singh BR (2006). Botulinum Neurotoxin Light Chain Refolds at Endosomal pH for its Translocation. Protein J 25, 455-462.
Finberg RW, and Kurt-Jones EA (2006). CD14: chaperone or matchmaker? Immunity 24, 127-129.
Goess BC, Hannoush RN, Chan LK, Kirchhausen T, and Shair MD (2006). Synthesis of a 10,000-membered library of molecules resembling carpanone and discovery of vesicular traffic inhibitors. J Am Chem Soc 128, 5391-5403.
Harris JB, Baresch-Bernal A, Rollins SM, Alam A, LaRocque RC, Bikowski M, Peppercorn AF, Handfield M, Hillman JD, Qadri F, Calderwood SB, Hohmann E, Breiman RF, Brooks WA, and Ryan ET (2006). Identification of in vivo-induced bacterial protein antigens during human infection with Salmonella enterica serovar Typhi. Infect Immun 74, 5161-5168.
Harrison R, Trujillo C, Tamayo, A., Harrison R, and Murphy JR (2006). Host cell factors involved in diphtheria toxin catalytic domain entry into eukaryotic cells. In Crossroads between bacerial protein toxins and host cell defenses., C. Fiorentini, and A. Fabbri, eds., pp. 17-41.
He Y, Li J, Li W, Lustigman S, Farzan M, and Jiang S (2006). Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein. J Immunol 176, 6085-6092.
Kuhn JH, Radoshitzky SR, Guth AC, Warfield KL, Li W, Vincent MJ, Towner JS, Nichol ST, Bavari S, Choe H, Aman, M. J., and Farzan M (2006). Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor. J Biol Chem 281, 15951-15958.
Kuhn JH, Radoshitzky SR, Li W, Kee Wong S, Choe H, and Farzan M (2006). The SARS coronavirus receptor ACE2 - a potential target for antiviral therapy. In New Concepts of Antiviral Therapy, E. Bogner, and A. Holzenburg, eds. (Sordrecht, The Netherlands, Springer).
Li W, Wong SK, Li F, Kuhn JH, Huang IC, Choe H, and Farzan M (2006). Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions. J Virol 80, 4211-4219.
Li F, Berardi M, Li W, Farzan M, Dormitzer PR, and Harrison SC (2006). Conformational states of the severe acute respiratory syndrome coronavirus spike protein ectodomain. J Virol 80, 6794-6800.
Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, and Kirchhausen T (2006). Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 10, 839-850.
Montminy SW, Khan N, McGrath S, Walkowicz MJ, Sharp F, Conlon JE, Fukase K, Kusumoto S, Sweet C, Miyake K, Akira S, Cotter RJ, Goguen JD, and Lien E (2006). Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response. Nat Immunol 7, 1066-1073.
Murphy JR, and Harrison R (2006). Mechanisms of bacterial protein toxin into the target cell cytosol. Drug Discovery Today: disease Mechanisms 3, 267-272.
Pelish HE, Ciesla W, Tanaka N, Reddy K, Shair MD, Kirchhausen T, and Lencer WI (2006). The Cdc42 inhibitor secramine B prevents cAMP-induced K+ conductance in intestinal epithelial cells. Biochem Pharmacol 71, 1720-1726.
Pelish HE, Peterson JR, Salvarezza SB, Rodriguez-Boulan E, Chen JL, Stamnes M, Macia E, Feng Y, Shair MD, and Kirchhausen T (2006). Secramine inhibits Cdc42-dependent functions in cells and Cdc42 activation in vitro. Nat Chem Biol 2, 39-46.
Sakhatskyy P, Wang S, Chou TH, and Lu S (2006). Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen. Virology 355, 164-174.
Szomolanyi-Tsuda E, Liang X, Welsh RM, Kurt-Jones EA, and Finberg RW (2006). Role for TLR2 in NK cell-mediated control of murine cytomegalovirus in vivo. J Virol 80, 4286-4291.
Trujillo C, Ratts R, Bharti A, vanderSpek J, Harrison R, and Murphy JR (2006). T1: A peptide motif essential for diphtheria toxin catalytic domain entry. Inter J Med Micro.
Trujillo C, Ratts R, Tamayo A, Harrison R, and Murphy JR (2006). Trojan horse or proton force: finding the right partner(s) for toxin translocation. Neurotox Res 9, 63-71.
Walsh SR, and Johnson RP (2006). Vaccinia Folliculitis following primary Dryvax vaccination. Infectious Diseases in Clinical Practice.
Wang JP, Liu P, Latz E, Golenbock DT, Finberg RW, and Libraty DH (2006). Flavivirus activation of plasmacytoid dendritic cells delineates key elements of TLR7 signaling beyond endosomal recognition. J Immunol 177, 7114-7121.
Xie J, Xu C, Hou Y, Young KL, Wang SX, Pourmond N, and Sun S (2006). Linking hydrophilic macromolecules to monodisperse magnetite (Fe3O4) nanoparticles via trichloro-s-triazine. Chemistry of Materials 18, 5401-5403.